AAVANTIBIO
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
245 1st St Ste 18, Cambridge, Massachuse...Phone Number
(352) 448-6551Website
www.aavantibio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About AAVANTIBIO
AavantiBio is a gene therapy company backed by a premier syndicate of life sciences investors including Perceptive Advisors, Bain Capital Life Sciences, and RA Capital Management, who led the company's recent $107 million Series A financing. Headquartered in Cambridge, Massachusetts, AavantiBio is advancing a diversified gene therapy pipeline in areas of high unmet medical need, including a lead program in Friedreich's Ataxia, a rare inherited genetic disease that causes cardiac and central nervous system dysfunction. The company benefits from strategic partnerships with the University of Florida's renowned Powell Gene Therapy Center and the MDA Care Center at UF Health where AavantiBio's co-founders and renowned gene therapy researchers Barry Byrne, M.D., Ph.D. and Manuela Corti, P.T., Ph.D. maintain their research and clinical practices.Explore more
AAVANTIBIO Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AAVANTIBIO your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at AAVANTIBIO
Earning: See what the market has to say on AAVANTIBIO recently announced quarterly report
Check if AAVANTIBIO has recently received funding, and reach out quickly before it becomes old news!
AAVANTIBIO, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if AAVANTIBIO is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once AAVANTIBIO has new funding data
Product Launch: Get notified when AAVANTIBIO launches new products
Click to see if AAVANTIBIO had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at AAVANTIBIO
Find 2 more new buyers
Compare Similar Companies to AAVANTIBIO
Compare insights from companies similar to AAVANTIBIO, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
51-200
Private
$147.5M
2018
RR
Renuka RamanathanVice President Head of Corporate & Business Development
Company Profile Activity
Activity Insights
AAVANTIBIO is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
AAVANTIBIO is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about AAVANTIBIO.
AAVANTIBIO Tech Stack
A closer look at the technologies used by AAVANTIBIO
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding AAVANTIBIO
Sign Up For FreeTo access detailed company insights
AavantiBio is a gene therapy company backed by a premier syndicate of life sciences investors including Perceptive Advisors, Bain Capital Life Sciences, and RA Capital Management, who led the company's recent $107 million Series A financing. Headquartered in Cambridge, Massachusetts, AavantiBio is advancing a diversified gene therapy pipeline in ar... Read More
